American Shared Hospital Services Sees Revenue Growth in Q2 2025

American Shared Hospital Services ( (AMS) ) has released its Q2 earnings. Here is a breakdown of the information American Shared Hospital Services presented to its investors.

American Shared Hospital Services (AMS) is a prominent provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, operating primarily in North and South America. The company specializes in leasing and direct patient care services, offering integrated cancer care solutions in collaboration with health systems and cancer networks.

In its latest earnings report for the second quarter of 2025, American Shared Hospital Services reported a 16% sequential increase in total revenue compared to the first quarter of 2025. Despite a slight 0.2% year-over-year revenue increase, the company saw a notable rise in treatment volumes, which is a positive indicator for its growth strategy.

Key financial metrics revealed a mixed performance. The Gamma Knife segment saw a 25% sequential revenue increase but a 5% year-over-year decrease. The LINAC segment experienced a 7% sequential and a 34% year-over-year revenue increase, showcasing the strength of AMS’s diversification strategy. However, the Proton Beam Radiation Therapy segment faced a 21% year-over-year revenue decline. The company’s net loss for Q2 2025 was $280,000, a significant drop from a net income of $3,602,000 in Q2 2024, largely due to the absence of a prior year’s net bargain purchase gain.

Looking ahead, AMS management remains optimistic about the company’s growth prospects. The planned installation of new equipment in Guadalajara, Mexico, and the expansion of radiation therapy centers in Rhode Island are expected to drive future growth. The company’s focus on operational efficiencies and strategic acquisitions is aimed at enhancing profitability and shareholder value in the long term.